Scientists from the German Cancer Research Center (DKFZ) and the stem cell institute HI-STEM* in Heidelberg have succeeded for the first time in directly reprogramming human blood cells into a previously unknown type of neural stem cell.
These induced stem cells are similar to those that occur during the early embryonic development of the central nervous system. They can be modified and multiplied indefinitely in the culture dish and can represent an important basis for the development of regenerative therapies.
Stem cells are considered to be the all-rounders of our tissues: they can multiply indefinitely and then – if they are pluripotent embryonic stem cells – generate all conceivable cell types. In 2006, the Japanese scientist Shinya Yamanaka recognized that such cells could also be produced in the laboratory – from mature body cells. Four genetic factors alone are sufficient to reverse the course of development and produce so-called induced pluripotent stem cells (iPS) that have identical properties to embryonic stem cells. Yamanaka was awarded the Nobel Prize for Medicine in 2012 for this discovery.
“This was a major breakthrough for stem cell research,” said Andreas Trumpp, German Cancer Research Center (DKFZ) and Director of HI-STEM in Heidelberg. “This applies in particular to for research in Germany, where the generation of human embryonic stem cells is not permitted. Stem cells have enormous potential both for basic research and for the development of regenerative therapies that aim to restore diseased tissue in patients. However, reprogramming is also associated with problems: For example, pluripotent cells can form germ line tumors, so-called teratomas.
Another possibility is not to completely turn back the course of development. For the first time, Trumpp’s team has succeeded in reprogramming mature human cells in such a way that a defined type of induced neural stem cells is produced that can multiply almost indefinitely. “We used four genetic factors like Yamanaka, but different ones for our reprogramming,” explains Marc Christian Thier, first author of the study. “We assumed that our factors would allow reprogramming to an early stage of development of the nervous system.”
In the past, other research groups also reprogrammed connective tissue cells into mature nerve cells or neural precursor cells. However, these artificially produced nerve cells often could not be expanded and could therefore hardly be used for therapeutic purposes. “Often, it was a heterogeneous mixture of different cell types that might not exist in the body under physiological conditions,” said Andreas Trumpp explaining the problems.
Together with stem cell researcher Frank Edenhofer from the University of Innsbruck and neuroscientist Hannah Monyer from DKFZ and the Heidelberg University Hospital, Trumpp and his team have succeeded in reprogramming different human cells: connective tissue cells of the skin or pancreas as well as peripheral blood cells. “The origin of the cells had no influence on the properties of the stem cells,” said Thier. In particular, the possibility of extracting neural stem cells from the blood of patients without invasive intervention is a decisive advantage for future therapeutic approaches.
What is special about the reprogrammed cells of the Heidelberg researchers is that they are a homogeneous cell type that resembles a stage of neural stem cells that occurs during the embryonic development of the nervous system. “Corresponding cells exist in mice and probably also in humans during early embryonic brain development,” said Thier. “We have described here a new neural stem cell type in the mammalian embryo.
These so called “induced Neural Plate Border Stem Cells” (iNBSCs) have a broad development potential. The iNBSCs of the Heidelberg scientists are expandable and multipotent and can develop in two different directions. On the one hand, they can take the path of development to mature nerve cells and their supplier cells, the glial cells, i.e. become cells of the central nervous system. On the other hand, they can also develop into cells of the neural crest, from which different cell types emerge, for example peripheral sensitive nerve cells or cartilage and bones of the skull.
The iNBSCs thus form an ideal basis for generating a broad range of different cell types for an individual patient. “These cells have the same genetic material as the donor and are therefore presumably recognized as “self” by the immune system and are not rejected,” explains Thier.
The CRISPR/Cas9 gene scissors can be used to modify the iNBSC or repair genetic defects, as the scientists have shown in their experiments. “They are therefore of interesting both for basic research and the search for new active substances and for the development of regenerative therapies, for example in patients with diseases of the nervous system. However until we can use them in patients, a lot of research work will still be necessary,” emphasizes Trumpp.
The Latest on: Regenerative medicine
via Google News
The Latest on: Regenerative medicine
- Global Translational Regenerative Medicines Market by Product Type, Therapy, Application and Geography - Forecast to 2026 - ResearchAndMarkets.comon July 25, 2019 at 1:53 pm
By geography, North America dominated the global regenerative medicine market owing to an increased number of leading companies and growth in the expansion of research and development activities ... […]
- Global Regenerative Medicine Market by Manufacturers, Types, Regions and Application Research Report Forecast to 2026on July 25, 2019 at 10:46 am
Jul 25, 2019 (Market Research Analyst via COMTEX) -- Big Market Research newly added the Global Regenerative Medicine Market Report that gives meticulous investigation of current scenario of the ... […]
- In sports medicine, regenerative treatments are finding successon July 25, 2019 at 8:06 am
Regenerative therapy treatments in orthopaedic medicine have been shown to help limit the need for pain medications and even surgery for some patients, which is why these noninvasive procedures with ... […]
- The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2019 Cell & Gene Meeting on the Mesaon July 24, 2019 at 4:03 pm
WASHINGTON, D.C., July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and ... […]
- Insilico Medicine to present at the XPOMET Medicinale Festival 2019on July 24, 2019 at 10:54 am
The festivals covers the new worlds of robotics, artificial intelligence, precision medicine, regenerative medicine, nanomedicine, wearables, Internet-of-Things for Healthcare, 3D printing and the ... […]
- Regenerative Medicine Products Showcase Approximately Progressing CAGR In Market Forecast Till 2025on July 24, 2019 at 6:47 am
Jul 24, 2019 (Global QYResearch via COMTEX) -- Global Regenerative Medicine Products Market is projected to grow at progressing CAGR over the forecast period 2019-2025 The global regenerative medicine ... […]
- Research in Regenerative Medicine proposes a quality control framework for umbilical cord blood-sourced allograftson July 22, 2019 at 7:47 am
The recent study from Burst Biologics challenges existing standards and outlines future safety and potency benchmarks. The prestigious peer-reviewed journal Regenerative Medicine has announced the ... […]
- Global Regenerative Medicine Markets, 2010-2018 - Market Driven by Kymriah and Yescartaon July 22, 2019 at 2:10 am
Dublin, July 22, 2019 (GLOBE NEWSWIRE) -- The "Global Market for Regenerative Medicine (RM), 2019" report has been added to ResearchAndMarkets.com's offering. The Regenerative Medicine (RM ... […]
- Iranian company manufactures 37 regenerative medicine productson July 19, 2019 at 12:45 am
The products have been manufactured using modern technologies and are available in the market, the head of the company Moayed Dehqanpour said. The products are in different fields of the wound ... […]
- Amoré Anti-Aging tops voting in Our City Media Readers' Choice Awards for Regenerative Medicineon July 17, 2019 at 5:19 pm
(MENAFN - PRLog) CORAL SPRINGS, Fla. - July 16, 2019 -PRLog-- Amoré Anti-Aging has been chosen by the readers of Our City Media's magazine in North Broward County, Florida as the top area ... […]
via Bing News